Skip to Content
Søk Menu

ASCO 2019: Data strongly support the recent FDA approval of cemiplimab

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Relateret indhold

Psychological and Behavioral Symptoms in Patients with Melanoma

/ Josefine Tingdal Taube Danielsen / Louise Strøm / Sofie Møgelberg Knutzen / Henrik Schmidt / Ali Amidi / Lisa M. Wu / Robert Bobby Zachariae
AngstDepresjonHudkreftLivskvalitetSøvnproblemer
Freya Bastrup

Electrochemotherapy for cutaneous tumors is a well-established treatment with a consistently high response rate

/ Freya Armstrong Bastrup
Hudkreft Play the Video 7:48

Occupation and cutaneous melanoma in the Nordic countries: A 45-year follow-up of 14,9 million people

/ Jose Hernán Alfonso
ArbeidsmiljøHudkreftKreftMelanom
Camillo Porta

New quality of life data with immune-based treatment of metastatic renal cell carcinoma

/ Camillo Porta
ESMO21Hudkreft Play the Video 9:16
hudkreft

Predicting a mutation in the melanoma predisposing gene CDKN2A

/ Håkan Olsson
HudkreftKreft

ESMO20: Dansk udviklet vaccine mod metastaserende melanom

/ Julie Westerlin Kjeldsen
ESMO20Hudkreft Play the Video 7:25

Merkel Cell Carcinoma – treatment news

/ Niels Junker
HudkreftKreft

Causes of non-melanoma skin cancer

/ Henrik F. Lorentzen
HudkreftKreft

Non-melanoma skin cancer (NMSC)

/ Carsten Sauer Mikkelsen / Kristian Bakke Arvesen / Luit Penninga / Peter Bjerring
HudkreftKreft
Back to top